Winton Group LTD Cara Therapeutics, Inc. Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$9.94 - $12.65 $201,941 - $256,997	-20,316 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$11.99 - $18.14 $245,183 - $370,944	-20,449 Reduced 50.16%	20,316 $247,000
Q3 2021 Oct 28, 2021	BUY	$11.55 - $16.06 $207,472 - $288,485	17,963 Added 78.78%	40,765 $630,000
Q2 2021 Aug 10, 2021	BUY	$12.38 - $29.19 $282,288 - $665,590	22,802 New	22,802 $325,000
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $292,445 - $371,534	-22,991 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$12.34 - $17.92 $50,655 - $73,561	-4,105 Reduced 15.15%	22,991 $293,000
Q2 2020 Aug 05, 2020	BUY	$12.39 - $17.33 $335,719 - $469,573	27,096 New	27,096 $463,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.